Ongoing Phase 1/2 Trial Advancing to Phase 2 Evaluation of Multi-Antigen Vaccine, Targeting both Spike and Nucleocapsid Proteins, as a Universal Booster to Current FDA-Approved ...

Fremont, CA – (NewMediaWire) – December 15, 2021 – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, ...

Statement Highlights: High blood pressure during pregnancy remains a major cause of maternal and fetal pregnancy-related complications and death, and it increases women’s short- ...